Innate lymphoid cells 2 (ILC2) in the transition from pediatric wheezing to asthma
M. Bonato (Padova, Italy), E. Bazzan (Padova, Italy), T. Maes (Ghent, Belgium), G. Brusselle (Ghent, Belgium), G. Turato (Padova, Italy), Y. Padrin (Padova, Italy), M. Turrin (Treviso, Italy), M. Cosio (Montreal, Canada), A. Barbato (Padova, Italy), M. Saetta (Padova, Italy), S. Baraldo (Padova, Italy)
Source: International Congress 2022 – Novel discoveries in immune (dys)function in lung disease
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
M. Bonato (Padova, Italy), E. Bazzan (Padova, Italy), T. Maes (Ghent, Belgium), G. Brusselle (Ghent, Belgium), G. Turato (Padova, Italy), Y. Padrin (Padova, Italy), M. Turrin (Treviso, Italy), M. Cosio (Montreal, Canada), A. Barbato (Padova, Italy), M. Saetta (Padova, Italy), S. Baraldo (Padova, Italy). Innate lymphoid cells 2 (ILC2) in the transition from pediatric wheezing to asthma. 2814
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
|
|